| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | Director | Common Stock | 18.6K | $107K | $5.74 | May 21, 2024 | Direct |
| Aurinia Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 15.2K | May 19, 2023 | Direct | ||
| Aurinia Pharmaceuticals Inc. | Director | Restricted Stock Units | 0 | May 18, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | May 21, 2024 | 1 | -$32.3K | 4 | May 22, 2024 | Director |
| AUPH | Aurinia Pharmaceuticals Inc. | May 18, 2023 | 5 | -$54.3K | 4 | May 23, 2023 | Director |
| AUPH | Aurinia Pharmaceuticals Inc. | May 18, 2022 | 2 | $0 | 4 | May 20, 2022 | Director |
| AUPH | Aurinia Pharmaceuticals Inc. | Mar 9, 2022 | 1 | $55K | 4 | Mar 11, 2022 | Director |
| AUPH | Aurinia Pharmaceuticals Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
| AUPH | Aurinia Pharmaceuticals Inc. | May 11, 2021 | 4 | $50.5K | 4 | May 13, 2021 | Director |